A2AAdenosine Receptor Activation Improves Survival in Mouse Models of Endotoxemia and Sepsis
Open Access
- 15 May 2004
- journal article
- conference paper
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 189 (10) , 1897-1904
- https://doi.org/10.1086/386311
Abstract
Background. Sepsis is currently treated with antibiotics and various adjunctive therapies that are not very effective.This publication has 10 references indexed in Scilit:
- Novel strategies for the treatment of sepsisNature Medicine, 2003
- Adenosine Deaminase Inhibition Attenuates Microvascular Dysfunction and Improves Survival in SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsisAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Inhibiting the inflammatory response in joint sepsisArthroscopy: The Journal of Arthroscopic & Related Surgery, 2001
- THE EPIDEMIOLOGY OF BACTERIAL SEPSISInfectious Disease Clinics of North America, 1999
- Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect.The Journal of Immunology, 1990
- Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.The Journal of Immunology, 1990
- Adenosine promotes neutrophil chemotaxis.The Journal of Experimental Medicine, 1988
- Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.The Journal of Experimental Medicine, 1983
- EFFECT OF SEPSIS ON TISSUE ADENINE-NUCLEOTIDE LEVELS1979